The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2
Open accessAbstract
Aims/hypothesis Islet autoantibodies are important in diabetes classification and risk assessment, and as endpoints in observational studies. The Diabetes Autoantibody Standardization Program (DASP) aims to improve and standardise measurement of autoantibodies associated with type 1 diabetes. We report results for glutamic acid decarboxylase autoantibodies (GADA) and islet antigen-2 autoantibodies (IA-2A) from three DASP workshops (2002--2005). Methods Up to 60 laboratories in 18 countries participated in each workshop. Participants received coded serum aliquots from 50 patients with newly diagnosed type 1 diabetes (median age 18 years, range 9-35 years) and 100 blood donor controls. Results were analysed using receiver operator characteristic (ROC) curves with sensitivity adjusted to 95% specificity in workshop controls. Results GADA assays performed well in all three workshops (median area under the ROC curve [AUC] 0.94; interquartile range 0.91-0.95) and performance was similar to DASP 2000. Performance of IA-2A assays improved over the workshop programme. Median AUC was 0.81 (interquartile range 0.79-0.83) in DASP 2002, 0.82 (interquartile range 0.78-0.84) in 2003, and 0.85 (interquartile range 0.82-0.87) in 2005 (p < 0.0001). Performance of GADA ELISA improved between 2002 and 2005, and, in DASP 2005, achieved higher median AUC and adjusted sensitivity than RIA. IA-2A ELISA improved and, in DASP 2005, achieved AUCs equivalent to in-house RIA. Assays using IA-2ic or full length IA-2 clones were more sensitive than those using IA-2bdc, with higher AUC (p = 0.004). Conclusions/interpretation GADA and IA-2A assays perform well in discriminating health and disease. The workshop format highlights systematic differences related to assay method and allows full evaluation of novel methods. The programme of autoantibody workshops in type 1 diabetes provides a model for other autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“That commercially available GAD65A and IA-2A methods are also participating in the DASP program demonstrates that it should be possible not only to harmonize participating laboratories but also eventually to standardize GAD65A and IA-2A (311).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [311]
In the citing paper
“Major efforts have been made to standardize GAD65A and IA-2A measurements (309,311).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [311]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Turner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay, I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03062-6 · Cited by 779
Gale, E. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15786-3 · Cited by 534
Verge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1857 · Cited by 420
Self-citationDiabetes Antibody Standardization Program: first assay proficiency evaluation
Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362
Self-citationIslet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity
Bonifacio, E. E., Genovese, S., Braghi, S., Bazzigaluppi, E., Lampasona, V., Bingley, P. J., Rogge, L., Pastore, M. R., Bognetti, E., Bottazzo, G. F., et al. (1995) · Diabetologia · doi:10.1007/s001250050358 · Cited by 178
Self-citationGreenbaum, C. J., Palmer, J. P., Kuglin, B., & Kolb, H. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.5.1569152 · Cited by 156
Stern, M., & Working Group on Serologic Screening for Celiac Disease (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200011000-00012 · Cited by 151
Bottazzo, G. F., & Gleichmann, H. (1986) · Diabetologia · doi:10.1007/bf00456124 · Cited by 143
Cited by
Sorted by citations
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Diabetes Care · doi:10.2337/dc11-9998 · Cited by 718
Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study
Uusitalo, U., Liu, X., Yang, J.-M., Aronsson, C., Hummel, S., Butterworth, M. D., Lernmark, Å., Rewers, M., Hagopian, W., She, J., et al. (2016) · JAMA pediatrics · doi:10.1001/jamapediatrics.2015.2757 · Cited by 253
Bonifacio, E., Yu, L., Williams, A. K., Eisenbarth, G. S., Bingley, P. J., Marcovina, S. M., Adler, K., Ziegler, A. G., Mueller, P. W., Schatz, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0293 · Cited by 291
Self-citationClinical Applications of Diabetes Antibody Testing
Bingley, P. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1365 · Cited by 278
Self-citationAge-related islet autoantibody incidence in offspring of patients with type 1 diabetes
the BABYDIAB-BABYDIET Study Group, Ziegler, A.-G., & Bonifacio, E. (2012) · Diabetologia · doi:10.1007/s00125-012-2472-x · Cited by 264
Self-citationMcDonald, T. J., Colclough, K., Brown, R., Shields, B. M., Shepherd, M. H., Bingley, P. J., Williams, A. J. K., Hattersley, A. T., & Ellard, S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03287.x · Cited by 237
Self-citationAutoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk
Achenbach, P., Lampasona, V., Landherr, U., Koczwara, K., Krause, S. W., Grallert, H., Winkler, C., Pflüger, M., Illig, T., Bonifacio, E. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1438-0 · Cited by 197
Self-citationPredicting Type 1 Diabetes Using Biomarkers
Bonifacio, E. E. (2015) · Diabetes Care · doi:10.2337/dc15-0101 · Cited by 191
Self-citationSteck, A. K., Vehik, K., Bonifacio, E., Lernmark, A., Ziegler, A.-G., Hagopian, W. A., She, J., Simell, O., Akolkar, B., Krischer, J., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2426 · Cited by 185
Self-citationDiabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies
Laboratories, P., Schlosser, M., Mueller, P. W., Törn, C., Bonifacio, E. E., & Bingley, P. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1915-5 · Cited by 180
Self-citationA plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes
Zhang, B., Kumar, R. B., Dai, H., & Feldman, B. J. (2014) · Nature Medicine · doi:10.1038/nm.3619 · Cited by 177
Role of Type 1 Diabetes–Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study
Törn, C., Hadley, D., Lee, H. S., Hagopian, W., Lernmark, Å., Simell, O., Rewers, M., Ziegler, A. G., Schatz, D., Akolkar, B., et al. (2014) · Diabetes · doi:10.2337/db14-1497 · Cited by 152
Self-citationRaab, J., Haupt, F., Scholz, M., Matzke, C., Warncke, K., Lange, K., Assfalg, R., Weininger, K., Wittich, S., Löbner, S., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011144 · Cited by 145
Self-citationVaarala, O., Ilonen, J., Ruohtula, T., Pesola, J., Virtanen, S. M., Härkönen, T., Koski, M., Kallioinen, H., Tossavainen, O., Poussa, T., et al. (2012) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2011.1559 · Cited by 127
Piemonti, L., Everly, M. J., Maffi, P., Scavini, M., Poli, F., Nano, R., Cardillo, M., Melzi, R., Mercalli, A., Sordi, V., et al. (2012) · Diabetes · doi:10.2337/db12-1258 · Cited by 132
Self-citationHoneyman, M. C., Stone, N. L., Falk, B. A., Nepom, G. T., & Harrison, L. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900709 · Cited by 124
Orban, T., Farkas, K., Jalahej, H., Kis, J. T., Treszl, A., Falk, B. A., Reijonen, H., Wolfsdorf, J. I., Ricker, A. T., Matthews, J. B., et al. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.10.005 · Cited by 128
Evidence That Nasal Insulin Induces Immune Tolerance to Insulin in Adults With Autoimmune Diabetes
Fourlanos, S., Perry, C., Gellert, S. A., Martinuzzi, E., Mallone, R., Butler, J., Colman, P. G., & Harrison, L. C. (2011) · Diabetes · doi:10.2337/db10-1360 · Cited by 118
Pflueger, M., Seppänen-Laakso, T., Suortti, T., Hyötyläinen, T., Achenbach, P., Bonifacio, E., Orešič, M., & Ziegler, A.-G. (2011) · Diabetes · doi:10.2337/db10-1652 · Cited by 112
Self-citationImmune therapy in type 1 diabetes mellitus
Lernmark, Å., & Larsson, H. E. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.237 · Cited by 109
Lampasona, V., Schlosser, M., Mueller, P. W., Williams, A. J. K., Wenzlau, J. M., Hutton, J. C., Achenbach, P., & Laboratories, P. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.170662 · Cited by 112
Self-citationElding Larsson, H., Vehik, K., Gesualdo, P., Akolkar, B., Hagopian, W., Krischer, J., Lernmark, Å., Rewers, M., Simell, O., She, J.-X., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12066 · Cited by 103
Lampasona, V., Pittman, D. L., Williams, A. J., Achenbach, P., Schlosser, M., Akolkar, B., Winter, W. E., Laboratories, P., Watson, K., Weets, I., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.304196 · Cited by 103
Self-citationBonifacio, E. E., Warncke, K., Winkler, C., Wallner, M., & Ziegler, A. (2011) · Diabetes · doi:10.2337/db11-0729 · Cited by 100
Self-citationSerum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes
Zhang, Q., Fillmore, T., Schepmoes, A., Clauss, T. R., Gritsenko, M. A., Mueller, P. W., Rewers, M., Atkinson, M. A., Smith, R. D., & Metz, T. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111843 · Cited by 97
Self-citationDecreased Cord-Blood Phospholipids in Young Age–at–Onset Type 1 Diabetes
Torre, D. L., Seppänen‐Laakso, T., Larsson, H. E., Hyötyläinen, T., Ivarsson, S. A., Lernmark, Å., Orešič, M., & and the DiPiS Study Group (2013) · Diabetes · doi:10.2337/db13-0215 · Cited by 97
Type 1 diabetes and polyglandular autoimmune syndrome: A review
Hansen, M. P. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.67 · Cited by 98
Distinguishing Persistent Insulin Autoantibodies With Differential Risk
Yu, L., Miao, D., Scrimgeour, L. A., Johnson, K. C., Rewers, M., & Eisenbarth, G. S. (2011) · Diabetes · doi:10.2337/db11-0670 · Cited by 91
Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes
Giannopoulou, E. Z., Winkler, C., Chmiel, R., Matzke, C., Scholz, M., Beyerlein, A., Achenbach, P., Bonifacio, E. E., & Ziegler, A. (2015) · Diabetologia · doi:10.1007/s00125-015-3672-y · Cited by 87
Self-citationEstablished and emerging biomarkers for the prediction of type 1 diabetes: a systematic review
Watkins, R. A., Evans‐Molina, C., Blum, J. S., & DiMeglio, L. A. (2014) · Translational research · doi:10.1016/j.trsl.2014.02.004 · Cited by 87
The environment and the origins of islet autoimmunity and Type 1 diabetes
Regnell, S. E., & Lernmark, Å. (2012) · Diabetic Medicine · doi:10.1111/dme.12099 · Cited by 86
Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients
Brooks-Worrell, B. M., Reichow, J. L., Goel, A., Ismail, H., & Palmer, J. P. (2011) · Diabetes Care · doi:10.2337/dc10-0579 · Cited by 83
Hawa, M. I., Buchan, A. P., Ola, T. O., Wun, C. C., DeMicco, D. A., Bao, W., Betteridge, D. J., Durrington, P. N., Fuller, J., Neil, H. A. W., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2383 · Cited by 85
Ziegler, A., Pflueger, M., Winkler, C., Achenbach, P., Akolkar, B., Krischer, J. P., & Bonifacio, E. E. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.02.004 · Cited by 81
Self-citationLernmark, Å., & Alshiekh, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.15001-5 · Cited by 79
Achenbach, P., Hummel, M., Thümer, L., Boerschmann, H., Höfelmann, D., & Ziegler, A. G. (2013) · Diabetologia · doi:10.1007/s00125-013-2896-y · Cited by 76
Weiß, A., Zapardiel‐Gonzalo, J., Voss, F., Jolink, M., Stock, J., Haupt, F., Kick, K., Welzhofer, T., Heublein, A., Winkler, C., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05780-9 · Cited by 79
Self-citationLamb, M. M., Yin, X., Zerbe, G. O., KLINGENSMITH, G. J., Dabelea, D., Fingerlin, T. E., Rewers, M., & Norris, J. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1428-2 · Cited by 75
Serum biomarkers for diagnosis and prediction of type 1 diabetes
Yi, L., Swensen, A., & Qian, W. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.009 · Cited by 80
Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients
Fazio, R., Malosio, M. L., Lampasona, V., Feo, D. D., Privitera, D., Marnetto, F., Centonze, D., Ghezzi, A., Comı, G., Furlan, R., et al. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509106851 · Cited by 71
Early Infant Diet and Islet Autoimmunity in the TEDDY Study
Uusitalo, U. M., Lee, H., Aronsson, C. A., Vehik, K., Yang, J., Hummel, S., Silvis, K., Lernmark, Å., Rewers, M. J., Hagopian, W., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1983 · Cited by 72
Self-citationHaller, M. J., Gitelman, S. E., Gottlieb, P. A., Michels, A. W., Perry, D. J., Schultz, A. R., Hulme, M. A., Shuster, J. J., Zou, B., Wasserfall, C. H., et al. (2016) · Diabetes · doi:10.2337/db16-0823 · Cited by 70
Howson, J. M. M., Stevens, H. E., Smyth, D. J., Walker, N. M., Chandler, K. A., Bingley, P. J., & Todd, J. A. (2011) · Diabetes · doi:10.2337/db11-0131 · Cited by 69
Self-citationHarmonization of immunoassays for biomarkers in diabetes mellitus
Hörber, S., Achenbach, P., Schleicher, E. D., & Peter, A. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.015 · Cited by 77
Winkler, C., Krumsiek, J., Lempainen, J., Achenbach, P., Grallert, H., Giannopoulou, E., Bunk, M., Theis, F. J., Bonifacio, E., & Ziegler, A.-G. (2012) · Genes & Immunity · doi:10.1038/gene.2012.36 · Cited by 68
Self-citationWinkler, C., Lauber, C., Adler, K., Grallert, H., Illig, T., Ziegler, A.-G., & Bonifacio, E. (2011) · Diabetes · doi:10.2337/db10-1269 · Cited by 68
Self-citationThe broad clinical phenotype of Type 1 diabetes at presentation
Merger, S. R., Leslie, R. D., & Boehm, B. O. (2012) · Diabetic Medicine · doi:10.1111/dme.12048 · Cited by 71
Raab, J., Giannopoulou, E. Z., Schneider, S., Warncke, K., Krasmann, M., Winkler, C., & Ziegler, A. (2014) · Diabetologia · doi:10.1007/s00125-014-3181-4 · Cited by 67
Sharma, A. K., Liu, X., Hadley, D., Hagopian, W., Chen, W., Önengüt-Gümüşcü, S., Törn, C., Steck, A. K., Frohnert, B. I., Rewers, M., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.008 · Cited by 71
Self-citationBeyond the Hormone: Insulin as an Autoimmune Target in Type 1 Diabetes
Brezar, V., Carel, J., Boîtard, C., & Mallone, R. (2011) · Endocrine Reviews · doi:10.1210/er.2011-0010 · Cited by 69
Serological autoantibody profiling of type 1 diabetes by protein arrays
Miersch, S., Bian, X., Wallstrom, G. L., Sibani, S., Logvinenko, T., Wasserfall, C. H., Schatz, D., Atkinson, M. A., Qiu, J., & LaBaer, J. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.10.018 · Cited by 64
My Child Is Islet Autoantibody Positive: Impact on Parental Anxiety
Johnson, S. B., Lynch, K. F., Roth, R., Schatz, D., & the TEDDY Study Group (2017) · Diabetes Care · doi:10.2337/dc17-0166 · Cited by 64
Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!
Rolandsson, O., & Palmer, J. P. (2010) · Diabetologia · doi:10.1007/s00125-010-1713-0 · Cited by 61
Advances in the Prediction and Natural History of Type 1 Diabetes
Bonifacio, E., & Ziegler, A. G. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.007 · Cited by 61
Self-citationAitken, R. J., Mehers, K. L., Williams, A. J. K., Brown, J., Bingley, P. J., Holl, R. W., Rohrer, T. R., Schober, E., Abdul-Rasoul, M. M., Hamilton-Shield, J. P., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1712 · Cited by 62
Self-citationGlycotoxin and Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 Diabetes
Beyan, H., Riese, H., Hawa, M. I., Beretta, G., Davidson, H. W., Hutton, J. C., Burger, H., Schlosser, M., Snieder, H., Boehm, B. O., et al. (2012) · Diabetes · doi:10.2337/db11-0971 · Cited by 60
Self-citationDelli, A. J., Larsson, H. E., Ivarsson, S. A., & Lernmark, Å. (2010) · Wiley eBooks · doi:10.1002/9781444324808 · Cited by 69
Steck, A. K., Larsson, H. E., Liu, X., Veijola, R., Toppari, J., Hagopian, W. A., Haller, M. J., Ahmed, S., Akolkar, B., Lernmark, Å., et al. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12485 · Cited by 56
Steck, A. K., Zhang, W., Bugawan, T. L., Barriga, K. J., Blair, A., Erlich, H. A., Eisenbarth, G. S., Norris, J. M., & Rewers, M. (2009) · Diabetes · doi:10.2337/db08-1179 · Cited by 52
3 Screen ELISA for High-Throughput Detection of Beta Cell Autoantibodies in Capillary Blood
Ziegler, A., Haupt, F., Scholz, M., Weininger, K., Wittich, S., Löbner, S., Matzke, C., Gezginci, C., Riethausen, S., Beyerlein, A., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0199 · Cited by 48
Self-citationAmoroso, M., Achenbach, P., Powell, M. J., Coles, R. L., Chlebowska, M., Carr, L., Furmaniak, J., Scholz, M., Bonifacio, E. E., Ziegler, A., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.08.013 · Cited by 48
Self-citationWilliams, A. J. K., Lampasona, V., Schlosser, M., Mueller, P. W., Pittman, D. L., Winter, W. E., Akolkar, B., Wyatt, R., Brigatti, C., Krause, S., et al. (2015) · Diabetes · doi:10.2337/db14-1693 · Cited by 46
Self-citationIndirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets
Nasr, M. B., D’Addio, F., Montefusco, L. B., Usuelli, V., Loretelli, C., Rossi, A., Pastore, I., Abdelsalam, A., Maestroni, A., Dell’Acqua, M., et al. (2022) · Diabetes · doi:10.2337/db21-0926 · Cited by 46
Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes
Sørgjerd, E. P. (2019) · Current Diabetes Reviews · doi:10.2174/1573399814666180730105351 · Cited by 47
Andersson, C., Kolmodin, M., Ivarsson, S.-A., Carlsson, A., Forsander, G., Lindblad, B., Ludvigsson, J., Kockum, I., Marcus, C., Samuelsson, U., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12093 · Cited by 44
Self-citationBonifacio, E. E., Pflüger, M., Marienfeld, S., Winkler, C., Hummel, M., & Ziegler, A. (2008) · Diabetologia · doi:10.1007/s00125-008-1022-z · Cited by 48
Self-citationAutoimmunity against INS-IGF2 Protein Expressed in Human Pancreatic Islets*
Kanatsuna, N., Taneera, J., Vaziri‐Sani, F., Wierup, N., Larsson, H. E., Delli, A. J., Skärstrand, H., Balhuizen, A., Bennet, H., Steiner, D. F., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478222 · Cited by 43
Self-citationIncomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin
Ashton, M. P., Eugster, A., Walther, D., Daehling, N., Riethausen, S., Kuehn, D., Klingel, K., Beyerlein, A., Zillmer, S., Ziegler, A., et al. (2016) · Scientific Reports · doi:10.1038/srep32899 · Cited by 43
Self-citationImmunology of β-Cell Destruction
Torre, D. L., & Lernmark, Å. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_24 · Cited by 43
Törn, C., Liu, X., Hagopian, W., Lernmark, Å., Simell, O., Rewers, M., Ziegler, A., Schatz, D., Akolkar, B., Önengüt-Gümüşcü, S., et al. (2016) · Scientific Reports · doi:10.1038/srep27887 · Cited by 39
Self-citationImmune Mechanisms and Pathways Targeted in Type 1 Diabetes
Jacobsen, L. M., Newby, B. N., Perry, D. J., Posgai, A. L., Haller, M. J., & Brusko, T. M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1066-5 · Cited by 42
Type 1 diabetes and associated autoimmune diseases
Frommer, L., & Kahaly, G. J. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i11.527 · Cited by 41
Jacobsen, L. M., Vehik, K., Veijola, R., Warncke, K., Toppari, J., Steck, A. K., Gesualdo, P., Akolkar, B., Lundgren, M., Hagopian, W., et al. (2022) · Diabetes Care · doi:10.2337/dc21-0422 · Cited by 44
Endesfelder, D., Hagen, M., Winkler, C., Haupt, F., Zillmer, S., Knopff, A., Bonifacio, E. E., Ziegler, A., zu Castell, W., & Achenbach, P. (2016) · Diabetologia · doi:10.1007/s00125-016-4050-0 · Cited by 43
Self-citationChapter 3 GAD65 Autoimmunity—Clinical Studies
Uibo, R., & Lernmark, Å. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00803-1 · Cited by 42
Zhang, Y., Feng, Z.-P., Naselli, G., Bell, F., Wettenhall, J. M., Auyeung, P., Ellis, J. A., Ponsonby, A., Speed, T. P., Chong, M. M. W., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.12.006 · Cited by 40
Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus
Monti, P., Heninger, A., & Bonifacio, E. E. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0020-y · Cited by 39
Self-citationGiannopoulou, E. Z., Puff, R., Beyerlein, A., von Luettichau, I., Boerschmann, H., Schatz, D., Atkinson, M. A., Haller, M. J., Egger, D., Burdach, S. E. G., et al. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12072 · Cited by 36
Gill, G. V., Tekle, A., Reja, A., Wile, D. B., English, P., Diver, M. J., Williams, A. J. K., & Tesfaye, S. H. (2010) · Diabetologia · doi:10.1007/s00125-010-1921-7 · Cited by 35
Awa, W. L., Schober, E., Wiegand, S., Herwig, J., Meissner, T., Schmidt, F., Molz, E., & Holl, R. W. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.011 · Cited by 35
Beta cell function during rapamycin monotherapy in long-term type 1 diabetes
Piemonti, L., Maffi, P., Monti, L., Lampasona, V., Perseghin, G., Magistretti, P., Secchi, A., & Bonifacio, E. E. (2010) · Diabetologia · doi:10.1007/s00125-010-1959-6 · Cited by 36
Self-citationPeptide serum markers in islet autoantibody-positive children
von Toerne, C., Laimighofer, M., Achenbach, P., Beyerlein, A., Gala, T. D. L. H., Krumsiek, J., Theis, F. J., Ziegler, A. G., & Hauck, S. M. (2016) · Diabetologia · doi:10.1007/s00125-016-4150-x · Cited by 35
What has zinc transporter 8 autoimmunity taught us about type 1 diabetes?
Williams, C. L., & Long, A. E. (2019) · Diabetologia · doi:10.1007/s00125-019-04975-x · Cited by 35
Burbelo, P. D., Hirai, H., Issa, A. T., Kingman, A., Lernmark, Å., Ivarsson, S. A., Notkins, A. L., & Iadarola, M. J. (2010) · Diabetes Care · doi:10.2337/dc09-1938 · Cited by 35
Petruželková, L., Ananieva-Jordanova, R., Včeláková, J., Vesely, Z., Štechová, K., Lebl, J., Dušátková, P., Šumnı́k, Z., Coles, R. L., Powell, M., et al. (2013) · Diabetic Medicine · doi:10.1111/dme.12308 · Cited by 34
Panimolle, F., Tiberti, C., Granato, S., Semeraro, A., Gianfrilli, D., Anzuini, A., Lenzi, A., & Radicioni, A. F. (2015) · Endocrine · doi:10.1007/s12020-015-0613-y · Cited by 35
Insulin and type 1 diabetes: immune connections.
Culina, S., Brezar, V., & Mallone, R. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0693 · Cited by 36
Role of humoral beta-cell autoimmunity in type 1 diabetes
Knip, M., Siljander, H., Ilonen, J., Simell, O., & Veijola, R. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12386 · Cited by 34
A classification and regression tree analysis identifies subgroups of childhood type 1 diabetes
Achenbach, P., Hippich, M., Zapardiel‐Gonzalo, J., Karges, B., Holl, R. W., Petrera, A., Bonifacio, E. E., & Ziegler, A. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104118 · Cited by 34
Self-citationRahmati, K., Lernmark, Å., Becker, C., Foltyn-Zadura, A., Larsson, K., Ivarsson, S.-A., & Törn, C. (2008) · PubMed · Cited by 32
Self-citationBonifacio, E. E., Krumsiek, J., Winkler, C., Theis, F. J., & Ziegler, A. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0526-2 · Cited by 32
Self-citationGAD autoantibody affinity in schoolchildren from the general population
Bender, C., Schlosser, M., Christen, U., Ziegler, A. G., & Achenbach, P. (2014) · Diabetologia · doi:10.1007/s00125-014-3294-9 · Cited by 32
Self-citationFalorni, A., Chen, S., Zanchetta, R., Yu, L., Tiberti, C., Bacosi, M. L., Furmaniak, J., Bini, V., Dotta, F., Eisenbarth, G. S., et al. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.04.012 · Cited by 31
Tiberti, C., Yu, L., Lucantoni, F., Panimolle, F., Spagnuolo, I., Lenzi, A., Eisenbarth, G. S., & Dotta, F. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04479.x · Cited by 31
Winkler, C., Raab, J., Grallert, H., & Ziegler, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035410 · Cited by 29
Heterogeneity in the aetiology of diabetes mellitus in young adults
Sahoo, S. K., Zaidi, G., Vipin, V. P., Chapla, A., Thomas, N., Yu, L., Asthana, P., & Bhatia, E. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1004_17 · Cited by 28
Awa, W. L., Boehm, B. O., Rosinger, S., Achenbach, P., Ziegler, A. G., Krause, S., Meißner, T., Wiegand, S., Reinehr, T., Kapellen, T. M., et al. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12043 · Cited by 27
Zaharieva, E., Velikova, T. V., Tsakova, A. D., & Kamenov, Z. A. (2017) · Journal of Diabetes Research · doi:10.1155/2017/9016148 · Cited by 28
T1D Autoantibodies: room for improvement?
Yu, L., Zhao, Z., & Steck, A. K. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000348 · Cited by 27
Metadata
- Authors
- Törn, C., Mueller, P. W., Schlosser, M., Bonifacio, E., Bingley, P. J., & Laboratories, P.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Universität Greifswald (DE)
- Center for Regenerative Therapies Dresden (DE)
- Southmead Hospital (GB)
- Corresponding author
- Bingley, P. J.
- Venue
- Diabetologia
- Published
- 2008-03-29
- Volume
- 51
- Issue
- 5
- Pages
- 846-852
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2098742390
- Cited by
- 284
- References
- 19
- Citations by year
- 2026: 9 · 2025: 6 · 2024: 7 · 2023: 14 · 2022: 15 · 2021: 14 · 2020: 7 · 2019: 17 · 2018: 13 · 2017: 12 · 2016: 20 · 2015: 16 · 2014: 19 · 2013: 23 · 2012: 27
- FWCI
- 11.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- National Institutes of Health (PL105-33)
- Centers for Disease Control and Prevention (106-554, PL 105-33, 107-360, 106-310)
- U.S. Public Health Service (106-554, PL105-33, 106-310, 107-360)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- type 1 diabetes, islet autoantibodies, glutamic acid decarboxylase antibodies, assay standardization, sensitivity and specificity, newly diagnosed type 1 diabetes
- MeSH terms
- Autoantibodies, Diabetes Mellitus, Glutamate Decarboxylase, Humans, ROC Curve, Sensitivity and Specificity, Receptor-Like Protein Tyrosine Phosphatases, Class 8
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
